Cargando…
Biological basis for novel mesothelioma therapies
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos. Although asbestos is banned in several countries, including the UK, an epidemic of mesothelioma is predicted to affect middle-income countries during this century owing to their heavy consumption of asbestos. The prog...
Autores principales: | Obacz, Joanna, Yung, Henry, Shamseddin, Marie, Linnane, Emily, Liu, Xiewen, Azad, Arsalan A., Rassl, Doris M., Fairen-Jimenez, David, Rintoul, Robert C., Nikolić, Marko Z., Marciniak, Stefan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505556/ https://www.ncbi.nlm.nih.gov/pubmed/34226685 http://dx.doi.org/10.1038/s41416-021-01462-2 |
Ejemplares similares
-
Use of preclinical models for malignant pleural mesothelioma
por: Shamseddin, Marie, et al.
Publicado: (2021) -
MesobanK UK: an international mesothelioma bioresource
por: Rintoul, Robert C, et al.
Publicado: (2016) -
The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma
por: Dalton, L E, et al.
Publicado: (2013) -
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
The uptake of metal–organic frameworks: a journey into the cell
por: Linnane, Emily, et al.
Publicado: (2022)